Stay updated on INCAGN01876 with Immune Therapies in Advanced Malignancies Clinical Trial

Sign up to get notified when there's something new on the INCAGN01876 with Immune Therapies in Advanced Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the INCAGN01876 with Immune Therapies in Advanced Malignancies Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    2%
    Check dated 2025-05-01T06:23:25.000Z thumbnail image
  2. Check
    15 days ago
    Change Detected
    Difference
    2%
    Check dated 2025-04-24T01:39:49.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study information regarding INCAGN01876 and its associated criteria, while a new version number has been added.
    Difference
    14%
    Check dated 2025-04-16T20:42:02.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.14.3 to v2.14.4.
    Difference
    2%
    Check dated 2025-04-09T16:04:16.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page has removed information about Malignant Mesothelioma and Renal Cell Carcinoma while adding details on Transitional Cell Carcinoma and Small Cell Lung Cancer.
    Difference
    1%
    Check dated 2025-04-02T00:33:17.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-03-25T19:52:17.000Z thumbnail image

Stay in the know with updates to INCAGN01876 with Immune Therapies in Advanced Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the INCAGN01876 with Immune Therapies in Advanced Malignancies Clinical Trial page.